USANA Health Sciences Inc (USNA) - Net Assets
Based on the latest financial reports, USANA Health Sciences Inc (USNA) has net assets worth $586.27 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($742.91 Million) and total liabilities ($156.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of USANA Health Sciences Inc to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $586.27 Million |
| % of Total Assets | 78.92% |
| Annual Growth Rate | 16.13% |
| 5-Year Change | 48.38% |
| 10-Year Change | 80.23% |
| Growth Volatility | 43.77 |
USANA Health Sciences Inc - Net Assets Trend (1995–2025)
This chart illustrates how USANA Health Sciences Inc's net assets have evolved over time, based on quarterly financial data. Also explore USANA Health Sciences Inc asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for USANA Health Sciences Inc (1995–2025)
The table below shows the annual net assets of USANA Health Sciences Inc from 1995 to 2025. For live valuation and market cap data, see USNA market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $586.27 Million | -0.01% |
| 2024-12-31 | $586.33 Million | +17.93% |
| 2023-12-31 | $497.20 Million | +14.44% |
| 2022-12-31 | $434.47 Million | +9.96% |
| 2021-12-31 | $395.12 Million | -10.53% |
| 2020-12-31 | $441.65 Million | +25.57% |
| 2019-12-31 | $351.71 Million | -10.08% |
| 2018-12-31 | $391.15 Million | +7.69% |
| 2017-12-31 | $363.21 Million | +11.66% |
| 2016-12-31 | $325.29 Million | +15.82% |
| 2015-12-31 | $280.85 Million | +22.02% |
| 2014-12-31 | $230.16 Million | -11.65% |
| 2013-12-31 | $260.52 Million | +40.39% |
| 2012-12-31 | $185.57 Million | +6.71% |
| 2011-12-31 | $173.91 Million | +19.80% |
| 2010-12-31 | $145.17 Million | +95.19% |
| 2009-12-31 | $74.37 Million | +133.61% |
| 2008-12-31 | $31.84 Million | -17.60% |
| 2007-12-31 | $38.64 Million | -35.81% |
| 2006-12-31 | $60.20 Million | +31.61% |
| 2005-12-31 | $45.74 Million | -4.40% |
| 2004-12-31 | $47.84 Million | +7.82% |
| 2003-12-31 | $44.37 Million | +145.24% |
| 2002-12-31 | $18.09 Million | +24.55% |
| 2001-12-31 | $14.53 Million | +12.85% |
| 2000-12-31 | $12.87 Million | -0.21% |
| 1999-12-31 | $12.90 Million | -57.84% |
| 1998-12-31 | $30.60 Million | +58.55% |
| 1997-12-31 | $19.30 Million | +55.65% |
| 1996-12-31 | $12.40 Million | +87.88% |
| 1995-12-31 | $6.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to USANA Health Sciences Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 77520.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $465.72 Million | 87.36% |
| Common Stock | $18.00K | 0.00% |
| Other Comprehensive Income | $-16.18 Million | -3.03% |
| Other Components | $83.54 Million | 15.67% |
| Total Equity | $533.10 Million | 100.00% |
USANA Health Sciences Inc Competitors by Market Cap
The table below lists competitors of USANA Health Sciences Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jumbo Interactive Ltd
AU:JIN
|
$338.76 Million |
|
NOCIL Limited
NSE:NOCIL
|
$338.90 Million |
|
Stalprodukt SA
WAR:STP
|
$338.93 Million |
|
Bharat Bijlee Limited
NSE:BBL
|
$339.01 Million |
|
ASYMCHEM LAB.(TIAN.)H YC1
F:7K90
|
$338.43 Million |
|
Palmer Square Capital BDC Inc.
NYSE:PSBD
|
$338.40 Million |
|
NEWRON PHARMACEUT. EO-20
F:NP5
|
$338.38 Million |
|
Beijing New Universal Science and Technology Co Ltd
SHE:300472
|
$338.34 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in USANA Health Sciences Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 532,109,000 to 533,104,000, a change of 995,000 (0.2%).
- Net income of 10,760,000 contributed positively to equity growth.
- Share repurchases of 27,507,000 reduced equity.
- Other comprehensive income increased equity by 6,492,000.
- Other factors increased equity by 11,250,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $10.76 Million | +2.02% |
| Share Repurchases | $27.51 Million | -5.16% |
| Other Comprehensive Income | $6.49 Million | +1.22% |
| Other Changes | $11.25 Million | +2.11% |
| Total Change | $- | 0.19% |
Book Value vs Market Value Analysis
This analysis compares USANA Health Sciences Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.70x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 139.46x to 0.70x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | $0.14 | $20.01 | x |
| 1996-12-31 | $0.24 | $20.01 | x |
| 1997-12-31 | $0.36 | $20.01 | x |
| 1998-12-31 | $0.55 | $20.01 | x |
| 1999-12-31 | $0.26 | $20.01 | x |
| 2000-12-31 | $0.33 | $20.01 | x |
| 2001-12-31 | $0.37 | $20.01 | x |
| 2002-12-31 | $0.44 | $20.01 | x |
| 2003-12-31 | $1.04 | $20.01 | x |
| 2004-12-31 | $1.17 | $20.01 | x |
| 2005-12-31 | $1.16 | $20.01 | x |
| 2006-12-31 | $1.61 | $20.01 | x |
| 2007-12-31 | $1.12 | $20.01 | x |
| 2008-12-31 | $0.98 | $20.01 | x |
| 2009-12-31 | $2.41 | $20.01 | x |
| 2010-12-31 | $4.55 | $20.01 | x |
| 2011-12-31 | $5.58 | $20.01 | x |
| 2012-12-31 | $6.22 | $20.01 | x |
| 2013-12-31 | $9.17 | $20.01 | x |
| 2014-12-31 | $8.41 | $20.01 | x |
| 2015-12-31 | $10.66 | $20.01 | x |
| 2016-12-31 | $12.99 | $20.01 | x |
| 2017-12-31 | $14.70 | $20.01 | x |
| 2018-12-31 | $15.87 | $20.01 | x |
| 2019-12-31 | $15.41 | $20.01 | x |
| 2020-12-31 | $20.78 | $20.01 | x |
| 2021-12-31 | $19.42 | $20.01 | x |
| 2022-12-31 | $22.50 | $20.01 | x |
| 2023-12-31 | $25.70 | $20.01 | x |
| 2024-12-31 | $27.77 | $20.01 | x |
| 2025-12-31 | $28.70 | $20.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently USANA Health Sciences Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.02%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.16%
- • Asset Turnover: 1.25x
- • Equity Multiplier: 1.39x
- Recent ROE (2.02%) is below the historical average (38.42%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 34.85% | 9.39% | 2.40x | 1.55x | $1.64 Million |
| 1996 | 40.32% | 8.82% | 2.69x | 1.70x | $3.76 Million |
| 1997 | 34.20% | 7.75% | 3.23x | 1.37x | $4.67 Million |
| 1998 | 31.05% | 7.81% | 3.04x | 1.31x | $6.44 Million |
| 1999 | 45.74% | 4.56% | 3.52x | 2.85x | $4.61 Million |
| 2000 | 22.27% | 2.33% | 3.47x | 2.76x | $1.58 Million |
| 2001 | 15.14% | 1.92% | 3.23x | 2.43x | $746.30K |
| 2002 | 47.00% | 6.36% | 3.42x | 2.16x | $6.69 Million |
| 2003 | 46.92% | 10.41% | 3.07x | 1.47x | $16.38 Million |
| 2004 | 64.33% | 11.28% | 3.81x | 1.50x | $25.99 Million |
| 2005 | 85.26% | 11.90% | 4.45x | 1.61x | $34.42 Million |
| 2006 | 68.55% | 11.03% | 3.74x | 1.66x | $35.25 Million |
| 2007 | 117.29% | 10.71% | 3.88x | 2.82x | $41.45 Million |
| 2008 | 94.06% | 6.98% | 3.50x | 3.85x | $26.76 Million |
| 2009 | 45.12% | 7.68% | 3.54x | 1.66x | $26.12 Million |
| 2010 | 31.45% | 8.82% | 2.54x | 1.40x | $31.13 Million |
| 2011 | 29.18% | 8.72% | 2.38x | 1.41x | $33.36 Million |
| 2012 | 35.80% | 10.24% | 2.43x | 1.44x | $47.88 Million |
| 2013 | 30.33% | 11.00% | 1.95x | 1.41x | $52.97 Million |
| 2014 | 33.30% | 9.69% | 2.25x | 1.52x | $53.62 Million |
| 2015 | 33.71% | 10.31% | 2.17x | 1.51x | $66.59 Million |
| 2016 | 30.75% | 9.94% | 2.14x | 1.45x | $67.51 Million |
| 2017 | 17.22% | 5.97% | 2.02x | 1.43x | $26.21 Million |
| 2018 | 32.27% | 10.61% | 2.14x | 1.42x | $87.11 Million |
| 2019 | 28.58% | 9.48% | 2.05x | 1.47x | $65.35 Million |
| 2020 | 28.23% | 10.99% | 1.77x | 1.45x | $80.50 Million |
| 2021 | 29.49% | 9.82% | 2.05x | 1.46x | $76.99 Million |
| 2022 | 15.96% | 6.94% | 1.67x | 1.37x | $25.90 Million |
| 2023 | 12.83% | 6.93% | 1.46x | 1.27x | $14.07 Million |
| 2024 | 7.90% | 4.92% | 1.14x | 1.41x | $-11.18 Million |
| 2025 | 2.02% | 1.16% | 1.25x | 1.39x | $-42.55 Million |
Industry Comparison
This section compares USANA Health Sciences Inc's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $851,608,847
- Average return on equity (ROE) among peers: -57.32%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| USANA Health Sciences Inc (USNA) | $586.27 Million | 34.85% | 0.27x | $338.50 Million |
| Above Food Ingredients Inc. Common Stock (ABVE) | $-46.26 Million | 0.00% | 0.00x | $34.25 Million |
| Agape ATP Corporation Common Stock (ATPC) | $2.30 Million | -3.27% | 0.00x | $2.64 Million |
| B&G Foods Inc (BGS) | $83.27 Million | 9.61% | 6.14x | $432.61 Million |
| BranchOut Food Inc. Common Stock (BOF) | $-5.14 Million | 0.00% | 0.00x | $52.50 Million |
| Bellring Brands LLC (BRBR) | $-453.90 Million | 0.00% | 0.00x | $1.30 Billion |
| BRC Inc. (BRCC) | $68.02 Million | -47.39% | 2.08x | $144.46 Million |
| BRF SA ADR (BRFS) | $8.81 Billion | 17.23% | 4.64x | $5.38 Billion |
| Bridgford Foods Corporation (BRID) | $50.80 Million | 17.13% | 0.49x | $68.08 Million |
| Borealis Foods Inc. (BRLS) | $4.64 Million | -566.46% | 12.96x | $32.19 Million |
| Better Choice Company Inc (BTTR) | $-1.18 Million | 0.00% | 0.00x | $5.13 Million |
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Ess… Read more